Improving Muslim Women's Uptake of Cancer Screening (IMCAN) (NCT06106165) | Clinical Trial Compass
CompletedNot Applicable
Improving Muslim Women's Uptake of Cancer Screening (IMCAN)
United Kingdom169 participantsStarted 2023-11-01
Plain-language summary
The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland.
The results of this trial will inform the development of a full-scale randomised-controlled trial.
Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.
Who can participate
Age range
25 Years – 74 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women from any ethnicity identifying as Muslim
* Muslim Women aged 25-74 years
* Muslim women living in North East England or Scotland
* Muslim women who are not up-to-date with all cancer screening they are eligible for; women who are up-to-date with one type of screening but not others would be eligible (for example, women might be up-to-date with breast cancer screening but not cervical or bowel cancer screening)
Exclusion Criteria:
* Women who do not identify as Muslim
* Women aged less than 25 years or older than 74 years
* Women who are up-to-date with all the screening they are eligible for
* Women who had either breast, cervical or bowel cancer before as their knowledge of the disease and treatment would differ from other women who do not have any prior experience with the disease
* Women who have had BReast CAncer gene testing and underwent mastectomy and/or hysterectomy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Difference on key domains between intervention modalities (online/face to face)
Timeframe: Baseline, 6 months, 12 months
10
The acceptability of the study engagement process to peer-educators
Timeframe: 12 months
11
The acceptability of the intervention and its implementation to participants and stakeholders, including intervention components and delivery mode (online/face-to-face)
Timeframe: 12 months
12
The acceptability of data collection methods used to participants and stakeholders